BioSpace News Archive

RNA Therapeutics Experience Renaissance Amidst Global Pandemic

RNA caught the public’s imagination in the form of mRNA vaccines against COVID-19, but RNA can be used in other ways, too, to make therapeutic proteins.

August 5, 2021
·
3 min read
·
Gail Dutton
FDA

Eisai and Biogen Gun for Speedy Approval for Another Alzheimer’s Drug

Eisai said that they have initiated communication with the FDA to achieve “the most optimal regulatory pathway” for lecanemab.

August 5, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

COVID-19 Vaccines: Employer Mandates, Boosters, New Studies and More

As the spread of the Delta variant exacerbates the COVID-19 pandemic, companies are increasingly moving toward requiring staffers to be vaccinated. Here’s a look at those stories and more.

August 5, 2021
·
4 min read
·
Mark Terry
Drug Development

Lung Cancer Drug Candidate Offers Patients Hope for Longer Life

The Phase III trial shows that PD-1 inhibitor Libtayo and platinum-doublet chemotherapy significantly improved OS compared with chemotherapy alone with locally advanced NSCLC.

August 5, 2021
·
2 min read
·
Brandon May
Drug Development

Study: Drug Candidate Improves Brain Energy Metabolism in Parkinson’s, MS

Top-line results from the Phase II REPAIR trial show a gold nanocrystal suspension, CNM-Au8®, significantly improved brain energetic metabolism in patients with Parkinson’s disease and multiple sclerosis.

August 5, 2021
·
3 min read
·
Brandon May
Job Trends

UK Watchdog Group Accuses Pfizer, Flynn Pharma of Price Gouging on Epilepsy Drug

A United Kingdom watchdog organization has accused Pfizer and Flynn Pharma of violating antitrust rules and overcharging that country’s National Health Services for anti-epilepsy treatments.

August 5, 2021
·
2 min read
·
Alex Keown
Deals

Bayer Drops $2 Billion to Drug the Undruggable

Under the terms of the agreement, Bayer is paying $1.5 billion upfront and up to $500 million in various milestone payments.

August 5, 2021
·
3 min read
·
Mark Terry
Drug Development

First-Ever Single-Dose Chikungunya Vaccine Touts Positive Phase III Results

The announcement for the chikungunya vaccine (VLA1553) comes after the U.S. FDA awarded it with a Breakthrough Designation status. Read more about it here.

August 5, 2021
·
2 min read
·
Vanessa Doctor, RN
Business

The World Takes Another Hit with Loss of Global Health Giant Dr. Tachi Yamada

Tadataka “Tachi” Yamada, a former GlaxoSmithKline and Takeda Pharmaceutical executive, early gene therapy backer, and philanthropist, passed away on Wednesday of natural causes at the age of 76.

August 5, 2021
·
2 min read
·
Heather McKenzie
Policy

CytoDyn Fights Back Against Activist Group

CytoDyn files a lawsuit against the activist group led by Rosenbaum and Patterson, alleging that they are “waging an illegal proxy contest to take over control of the Company’s Board of Directors.”

August 5, 2021
·
3 min read
·
Mark Terry